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Smoking motivesThe current study examined the moderating effects of smoking amount per day on the relation between anxiety
sensitivity and nicotine dependence, cigarette smoking outcome expectancies, and reasons for quitting smoking
among 465 adult, treatment-seeking smokers (48% female; Mage = 36.6, SD= 13.5). Smoking amount per day
moderated the relation between anxiety sensitivity and nicotine dependence, smoking expectancies for negative
consequences and appetite control as well as intrinsic reasons for quitting. However, no moderating effect
was evident for negative reinforcement expectancies. The form of the signiﬁcant interactions indicated across
dependent variables lower levels of smoking amount per day suppressed the relation between anxiety sensitivity
and smoking related dependent variable, such that the positive relation of anxiety sensitivity to smoking
dependence and cognitive–affective aspects of smoking is weaker in heavier smokers and more robust in lighter
smokers.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Smoking amount per day moderates the relation of anxiety sensi-
tivity for smoking dependence and cognitive–affective aspects of
smoking among treatment-seeking smokers
Anxiety disorders are among the most common psychiatric condi-
tions (Kessler, Chiu, Demler, & Walters, 2005). Numerous clinical and
epidemiological studies indicate higher amount per days of smoking
among the anxiety-disordered population relative to both persons
with no psychiatric illness as well as thosewith other psychiatric condi-
tions (Lasser et al., 2000;McCabe et al., 2004). Onemeans of elucidating
the role of anxiety in smokingmaintenance and dependence is to inves-
tigate the inﬂuence of transdiagnostic psychological vulnerability
factors that inﬂuence anxiety-related conditions on smoking. Anxiety
sensitivity is one of the transdiagnostic vulnerability factors that reﬂect
the tendency to fear anxiety-related sensations (Reiss, Peterson, Gursky,
& McNally, 1986). Indeed, anxiety sensitivity is a core transdiagnostic
vulnerability factor for the etiology and maintenance of multiple
anxiety disorders (e.g., panic and social anxiety) and other emotional
disorders (e.g., depression and PTSD; Hayward, Killen, Kraemer, &. This is an open access article underTaylor, 2000; Maller & Reiss, 1992; McNally, 2002; Marshall, Miles, &
Stewart, 2010; Schmidt, Lerew, & Jackson, 1999; Schmidt, Zvolensky,
& Maner, 2006; Taylor, 2003).
Recent research also indicates that anxiety sensitivity is associated
with, and may contribute to, numerous aspects of smoking behavior.
For example, anxiety sensitivity is positively correlated with smoking
motives and expectancies for negative affect reduction as well as
expectancies for negative consequences and sensorimotor effects
(e.g., appetite control) of smoking (Comeau, Stewart, & Loba, 2001;
Johnson, Farris, Schmidt, Smits, & Zvolensky, 2013; Leyro, Zvolensky,
Vujanovic, & Bernstein, 2008; Novak, Burgess, Clark, Zvolensky, &
Brown, 2003). From a cessation perspective, smokers higher relative
to lower in anxiety sensitivity perceive quitting as more difﬁcult
(Zvolensky, Vujanovic, et al., 2007b), experience more intense nicotine
withdrawal during smoking deprivation (Johnson, Stewart, Rosenﬁeld,
Steeves, & Zvolensky, 2012; Langdon et al., 2013; Marshall, Johnson,
Bergman, Gibson, & Zvolensky, 2009; Vujanovic & Zvolensky, 2009;
Zvolensky, Lejuez, Kahler, & Brown, 2004b), and are at greater odds of
early lapse/relapse (Assayag, Bernstein, Zvolensky, Steeves, & Stewart,
2012; Brown, Kahler, Zvolensky, Lejuez, & Ramsey, 2001; Zvolensky,
Bernstein et al., 2007a; Zvolensky, Stewart, Vujanovic, Gavric, & Steeves,
2009; Zvolensky, Bonn-Miller, Bernstein, &Marshall, 2006). Importantly,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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smoking amount per day, nicotine dependence, gender, other concur-
rent substance use (e.g., alcohol, cannabis), panic attack history, or
trait-like negative mood propensity (Johnson et al., 2013; Wong et al.,
2013).
Although promising, extant work has only begun to explore the
interplay between anxiety sensitivity and differing levels of smoking
behavior. Research has found that anxiety sensitivity moderates daily
smoking amount per day in regard to the expression of anxiety
symptoms and catastrophic thinking, such that higher levels of anxiety
sensitivity and higher smoking amount per day are associated with
greater anxiety (Leen-Feldner et al., 2007; McLeish, Zvolensky, &
Bucossi, 2007; McLeish, Zvolensky, Del Ben, & Burke, 2009; Zvolensky,
Kotov, Antipova, & Schmidt, 2003a). Integrative models of anxiety-
smoking comorbidity posit that anxiety sensitivity may similarly inter-
play with smoking amount per day in relation to smoking processes,
but possibly in a different manner (Zvolensky & Bernstein, 2005).
Namely, smoking amount per day may diminish the relation between
anxiety sensitivity and certain processes that relate to nicotine depen-
dence and cognitive–affective aspects of smoking addiction at lower
levels of anxiety sensitivity. Speciﬁcally, even lower smoking amount
per day may be sufﬁcient to elicit internal sensations that trigger
catastrophic thinking (e.g., “I'm going to die”; “I am losing control”).
Despite this possibility, no research has examined the moderating role
of smoking rate per day on the relations between anxiety sensitivity
and smoking-related processes, leaving a clinically signiﬁcant gap in
extant knowledge. Although the average cigarette consumption per
smoker has decreased since the 1990s, nicotine dependence levels
among smokers have remained stable (Jarvis, Giovino, O'Connor,
Kozlowski, & Bernet, 2014). Thus, the exploration of factors that may
inﬂuence the maintenance of smoking and smoking-based processes
represents an important area of study.
Together, the present investigation evaluated themoderating role of
smoking amount per day in regard to the relations between anxiety
sensitivity and nicotine dependence, outcome expectancies (mood
and sensorimotor) for smoking, and intrinsic reasons for quitting
among daily smokers seeking treatment for smoking cessation. It was
hypothesized that smoking amount per day would moderate the effect
of anxiety sensitivity in regard to nicotine dependence, smoking out-
come expectancies (negative consequences, negative reinforcement/
negative affect reduction, and appetite control), and (intrinsic) reasons
for quitting among smokers with lower (versus higher) smoking
amount per day. These outcomes were chosen as dependent variables
as they consistently are related to smoking behavior (Brandon &
Baker, 1991), and thus, represent important targets for study and treat-
ment development. Speciﬁcally, it was expected that lower levels of
smoking amount per day would suppress the relation between anxiety
sensitivity and smoking related dependent variable, such that the
positive relation of anxiety sensitivity to smoking dependence and
cognitive–affective aspects of smoking is weaker in heavier smokers
and more robust in lighter smokers. It was additionally hypothesized
that these associations would be found above and beyond the effects
of other variables that affect smoking/anxiety relations, including
gender, negative affectivity, alcohol use, medical problems, DSM-IV
deﬁned Axis-I disorders, and substance use.
2. Method
2.1. Participants
Participants included 465 adult smokers (48% female; Mage = 36.6,
SD = 13.5) who responded to study advertisements (e.g., ﬂyers, news-
paper ads, radio announcements). In terms of ethnic background, 85.6%
of participants identiﬁed as Caucasian, 7.9% identiﬁed as African–
American, 2.9% identiﬁed as Hispanic, 1.1% identiﬁed as Asian, and
2.5% identiﬁed as “other.” Participants reported smoking an average of16.5 cigarettes per day (SD = 9.9), smoking their ﬁrst cigarette at
14.8 years of age (SD= 3.4), and initiating regular (daily) smoking at
17.4 years of age (SD = 3.7). The average score on the Fagerström
Test for Nicotine Dependence (Heatherton, Kozlowski, Frecker, &
Fagerström, 1991) was 5.1 (SD = 2.3), indicating moderate levels of
nicotine dependence. Participants were compensated $12.50 in cash
for participation in the baseline appointment.
As determined by the baseline Structured Clinical Interview for
DSM-IV Axis I Disorders-Non-Patient Version (SCID-I/NP; First, Spitzer,
Gibbon, & Williams, 2007), 44.3% of the sample met criteria for current
(past year) Axis I psychopathology, with 21% meeting criteria for more
than one diagnosis. The most common diagnoses were social anxiety
disorder (14.3%), GAD, (8.5%), and current MDD (7%). Among partici-
pants with current psychopathology, the average number of diagnoses
per participant was 1.4 (SD= 0.5).
Participants were excluded based on the following criteria:
(1) current (past month) use of pharmacotherapy for smoking cessa-
tion; (2) limited mental competency and inability to provide informed,
voluntary,written consent; (3) endorsement of current or past psychotic-
spectrum symptoms via structured interview screening; and (4) current
suicidality or homicidality.2.2. Measures
2.2.1. Demographic questionnaire
Demographic information collected included age, gender, race,
educational attainment, marital status, and employment. These data
were used for descriptive purposes, and gender was used as a covariate
in all analyses.2.2.2. Structured Clinical Interview-Non-Patient Version for DSM-IV (SCID-
N/P; First et al., 2007)
Diagnostic assessments for Axis I disorders and substance use
disorders were performed using the SCID-N/P. The interviews were
administered by trained staff and supervised by independent doctoral-
level psychologists. All interviews were audio-taped and the reliability
of a randomselection of approximately 12.5%of interviewswas checked
(MJZ) for accuracy; no cases of diagnostic coding disagreement were
noted.2.2.3. Smoking History Questionnaire (SHQ; Brown, Lejuez, Kahler, &
Strong, 2002)
The SHQ is a self-report questionnaire used to assess smoking
history and pattern (e.g., smoking amount per day, age of onset of initi-
ation). It has been successfully used in previous studies as a measure of
smoking history (Zvolensky et al., 2004b). The present study utilized
this measure to describe the sample holistically, and the item “average
number of cigarettes per day” to index smoking amount per day.2.2.4. Medical history form
Current and lifetime medical illnesses and current use of prescribed
medication were assessed using a medical history checklist. For current
and lifetime medical illnesses, a composite variable was computed for
the present study as an index of tobacco-related medical illnesses,
whichwas used as a covariate in all models. Items inwhich participants
indicated having ever been diagnosed (respiratory disease, asthma,
heart problems, and hypertension, all coded 0 = no, 1 = yes) were
summed to create a total score (observed range from0 to 4),with greater
scores reﬂecting the presence of multiple markers of tobacco-related
medical illnesses. The medical history form has been utilized as an
indicator of medical problems among cigarette smokers in other work
(e.g., Zvolensky, Farris, Leventhal, & Schmidt, 2014).
1 In order to ensure that the primary associations are not due to suppression or other
effects of the covariates, a separate set of analyses were run in which the covariates were
entered as a block in the ﬁnal step of the regression analyses. Our analyses remained the
same using this alternative post hoc method.
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Babor, de la Fuente, & Grant, 1993)
The AUDIT is a 10-item self-report measure developed to identify
individuals with problematic drinking. Its scores range from 0 to 30,
with higher scores reﬂecting more problematic drinking. In the current
study, AUDIT scorewas used to index level of alcohol consumption. Psy-
chometric properties for the AUDIT arewell documented (e.g., Saunders
et al., 1993). In the current investigation, internal consistency for the
AUDIT total score was good (Cronbach's α= .89).
2.2.6. Positive and Negative Affect Scale (PANAS; Watson, Clark, & Tellegen,
1988)
The PANAS is a self-report measure on which participants rate the
extent to which they experience each of 20 different feelings and
emotions (e.g., interested, nervous) on a Likert-type scale (1 = “very
slightly or not at all” to 5 = “extremely”). The measure yields two
factors (negative and positive affect) with strong documented psycho-
metric properties. The negative affectivity subscale (PANAS-NA) inter-
nal consistency was good in the present sample (Cronbach's α= .88).
2.2.7. Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007)
The ASI-3 is an 18-item self-report measure of the sensitivity to, and
fear of the potential negative consequences of anxiety-related symp-
toms and sensations. The ASI-3 was derived, in part, from the original
ASI (Reiss & McNally, 1985). The ASI-3 is a self-report measure on
which participants rate the extent to which they concerned about the
possible negative consequences of anxiety (e.g. “It scares me when my
heart beats fast”) on a Likert-Type scale (0 = very little to 4 = very
much). In the present study, we utilized the ASI-3 total score (sum of
scores for all 18 ASI-3 items; score ranges from 0 to 72). Internal consis-
tency of ASI-III was good (Cronbach's alpha = .90).
2.2.8. Fagerström Test for Nicotine Dependence (FTND; Heatherton et al.,
1991)
This instrument is a well-established six-item scale designed to
assess gradations in nicotine dependence. This measure exhibits
adequate internal consistency, high degrees of test–retest reliability
(Pomerleau, Carton, Lutzke, Flessland, & Pomerleau, 1994), and positive
relationswith key smoking variables (e.g., salivary cotinine; Heatherton
et al., 1991; Payne, Smith, McCracken, McSherry, & Antony, 1994). The
FTND demonstrated typical-range internal consistency among the pres-
ent study sample (Cronbach's alpha = .60; Korte, Capron, Zvolensky, &
Schmidt, 2013).
2.2.9. Smoking Consequences Questionnaire (SCQ; Brandon & Baker, 1991)
The SCQ is a 50-item self-report measure on which respondents
indicate, on a 10-point Likert-type scale (0 = completely unlikely to
10 = completely likely), an individual's expectancies about cigarette
smoking. The SCQ includes four subscales: positive reinforcement
(15 items; e.g. “I enjoy the taste sensations while smoking”), negative
reinforcement/negative affect reduction (12 items; e.g., “Smoking
helps me calm down when I feel nervous”), negative consequences
(18 items; e.g., “The more I smoke, the more I risk my health”), and
appetite control (5 items; “Smoking helps me control my weight”).
The SCQ and its constituent factors have excellent psychometric proper-
ties (Brandon & Baker, 1991; Buckley et al., 2005; Downey & Kilbey,
1995). In the present study, the SCQ subscales demonstrated good
internal consistency with Cronbach alphas ranging from .82 to .89. The
negative consequences, negative reinforcement/negative affect reduc-
tion, and appetite control were employed in the current investigation,
as they were theoretically apt to interplay with anxiety sensitivity
(Leventhal & Zvolensky, 2015).
2.2.10. Reasons for Quitting Scale (RFQ; Curry, Wagner, & Grothaus, 1990)
The RFQ is composed of 20 self-report items and measures intrinsic
and extrinsic motivation for quitting smoking. The RFQ consists of twointrinsic motivation subscales: self-control (“To show myself I can quit
if I really want to”) and health concerns (“Because I'm concerned that
smoking will shorten my life”), and two extrinsic motivation subscales:
immediate reinforcement (“To save money that I spend on cigarettes”)
and social pressure (“Because someone has given me an ultimatum to
quit”). The RFQ has demonstrated good psychometric properties in
past work (Curry, McBride, Grothaus, Louie, & Wagner, 1995). In the
present study, only the two intrinsic motivation subscales of the
SCQ—health concerns and self-control—were utilized (Cronbach alphas
.87 and .90, respectively). The two extrinsic subscales were not
employed because therewas no theoretical basis to suggest that anxiety
sensitivity would be related to this type of reason for quitting.
2.3. Procedure
Interested participants who met the initial requirements during a
telephone screen were scheduled to come in for a structured clinical
interview to assess the presence or absence of any Axis I condition. Indi-
vidualswhowere deemed eligible after the screening/interviewprocess
were then scheduled to come in for a baseline appointment to complete
various demographic, smoking, anxiety, and substance use assessments,
presented in the same order to each participant. Following written
informed consent, participants were interviewed using the SCID-I/NP
and completed a computerized self-report battery. The study protocol
was approved by the Institutional Review Boards at the University
of Vermont and Florida State University (clinicaltrials.gov #
NCT01753141). The current study is based on secondary analyses of
baseline (pre-treatment) data for a subset of the sample, which was
selected on the basis of complete data for all studied variables.
2.4. Analytic strategy
First, a series of zero-order correlations were conducted to examine
associations between study variables. To test the main and interactive
affects effects of anxiety sensitivity and smoking amount per day on
the criterion variables, a Generalized Linear Modeling (GLM) in Proc
GLM (SAS 9.4) was employed. Speciﬁcally, hierarchical regression
analyses were conducted. In the ﬁrst step of each model, gender
(coded as male/female), tobacco-related medical illness (total number
of illnesses as indicated on the Medical Screening Questionnaire),
alcohol consumption (as determined by the AUDIT), negative affectivity
(as determined by the PANAS), non-alcohol substance abuse problems
(as determined by the SCID-N/P), and current Axis I disorders (as
determined by the SCID-N/P) were entered as covariates (see 1). Next,
anxiety sensitivity and smoking amount per day were entered (second
step). Finally, the interaction term between smoking amount per day
and anxiety sensitivity was entered at the third step. Continuous
variables were grand mean centered. Nicotine dependence, smoking
expectancies, and reasons for quitting were examined as dependent
variables in separate conceptually-nested models. Given the multiple
hypotheses tested in this analysis, a False Discovery Rate (FDR) control
test was used to control for Type-I error (Benjamini & Hochberg, 1995).
3. Results
3.1. Descriptive data
Descriptive data and correlations of the all variables included in the
models are presented in Table 1. Anxiety sensitivity was signiﬁcantly
and positively related with all outcome variables. Smoking amount
per day was signiﬁcantly and positively correlated with RFQ-health
Table 1
Zero-order correlations among theoretically-relevant variables.
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14
1. Gendera 1 .14** − .11* .00 .19** − .02 − .08 .08 − .01 .18** .16** .26** .17** .09
2. Negative affectb 1 .24** .01 .39** .14** .00 .63** .06 .38** .18** .11* .11* .05
3. AUDITc 1 − .11* .09 .18** − .06 .21** − .12* .16** .07 .01 − .01 .01
4. Medical problemsd 1 .08* − .08 .00 .01 − .02 .− .10* .02 .00 .14** .10*
5. Axis-I disordere 1 .09 .03 .36** .13** .20** .05 .11* .09* .12**
6. Substance usee 1 − .03 .15** − .04 .03 − .07 .03 − .07 .00
7. Cig per dayf 1 .01 .57** .02 .06 .04 .09 .05
8. ASg 1 .14** .30** .16** .13** .22** .18**
9. FTNDh 1 .18** .18** .17** .21** .18**
10. SCQ negative reinforcementi 1 .39** .42** .15** .11*
11. SCQ negative consequencesi 1 .26** .54** .25**
12. SCQ appetite controli 1 .12** .13**
13. RFQ health concernsj 1 .32**
14. RFQ self controlj 1
Mean (or n) 465 19.06 6.19 .36 250 1.08 16.82 15.14 5.14 6.50 5.15 6.55 14.49 14.62
SD (or %) 48%(female) 7.06 6.01 .62 44.3% .28 9.05 12.28 2.28 1.25 2.37 1.28 3.84 4.01
Note: aGender = % listed are females (coded 0 =male; 1 = female). bNA = Positive and Negative Affect Scale—Negative Affect subscale. cAUDIT = Alcohol Use Disorders Identiﬁcation
Test—total score. dMedical problems = tobacco-related medical illnesses per the Medical Screening Questionnaire. eAxis I Disorder = Current Axis I disorder per the Structured Clinical
Interview—Non-Patient Version for DSM-IV. eSubstance use = current non-alcohol substance abuse/dependence diagnosis per the Structured Clinical Interview—Non-Patient Version
for DSM-IV. fCPD = number of cigarettes per day during past week per the Smoking History Questionnaire. gAS = Anxiety Sensitivity Index-III—total score. hFTND = Fagerstrom Test
for Nicotine Dependence; iSCQ negative consequences, iSCQ appetite control, iSCQ negative reinforcement= the subscales of Smoking Consequences Questionnaire. jRFQ health concerns
and jRFQ self-control = the subscales of Reasons for Smoking Scale.
* p b .05.
** p b .01.
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were not signiﬁcantly related, sharing approximately 0.01% variance.
3.2. GLM analyses
3.2.1. Nicotine dependence
In terms of nicotine dependence, covariates entered at the ﬁrst step
accounted for a signiﬁcant amount of variance (R2 = .04, F(10, 455) =
32.3, p b .01). Please refer to Table 1 for the signiﬁcant covariate effects.
At the second step, both smoking amount per day and anxiety
sensitivity were signiﬁcant predictors (b = .14, p b .001; b = .03,
p b .01, respectively). The interaction term for anxiety sensitivity and
smoking amount per day was signiﬁcant (b=− .001, p b .05; Table 2).
Simple slope analyses revealed that anxiety sensitivity predicted greater
levels of nicotine dependence among lighter (versus heavier) smokers
(b= .04, p b .001 and b= .02, p= .09 for lighter and heavier smokers
respectively; see Fig. 1).
3.2.2. Smoking expectancies
In termsof negative consequences expectancies, covariates accounted
for a signiﬁcant amount of variance (R2 = .07, F(10, 455) = 5.4,
p b .0001). Please refer to Table 1 for signiﬁcant covariate effects. No
signiﬁcant effects emerged at the second step. The interaction term
for anxiety sensitivity and smoking amount per day was signiﬁcant
(b = − .001, p b .05; Table 2). Simple slope analyses revealed that
anxiety sensitivity predicted greater levels of negative consequences
expectancies among lighter (versus heavier) smokers (b = .02, p =
.01 and b=− .0002, p=.98 for lighter and heavier smokers respective-
ly; see Fig. 1).
In terms of negative affect reduction expectancies, covariates
entered at the ﬁrst step accounted for a signiﬁcant amount of variance
(R2 = .09, F(10, 455)= 5.1, p b .0001). Please refer to Table 1 for signif-
icant covariate effects. Therewere no signiﬁcant predictors at levels two
or three in the model.
In terms of appetite control expectancies, covariates entered at the
ﬁrst step accounted for a signiﬁcant amount of variance (R2 = .07,
F(10, 455) = 6.2, p b .0001). Please refer to Table 1 for signiﬁcant
covariate effects. No signiﬁcant effects were evident at the second step.
The interaction term was signiﬁcant (b = − .002, p b .01; Table 2).
Simple slope analyses revealed that anxiety sensitivity predicted greater
appetite control expectancies among lighter (versus heavier) smokers(b = .04, p = .004 and b = .0001, p = .99 for lighter and heavier
smokers respectively; see Fig. 1).
3.2.3. Intrinsic reasons for quitting
In terms of reasons for quitting related to health concerns, covariates
entered at the ﬁrst step accounted for a signiﬁcant amount of variance
(R2 = .06, F(10, 455) = 4.2, p b .0001). Please refer to Table 1 for
signiﬁcant covariate effects. Anxiety sensitivity was the only signiﬁcant
predictor at step two (b = .04, p b .001). The interaction term
for smoking amount per day was signiﬁcant (b = − .003, p b .05;
Table 2). Simple slope analyses revealed that anxiety sensitivity
predicted reasons for quitting related to health concerns among both
light and heavy smokers. However, in line with the signiﬁcant interac-
tive effect, the change slopewas steeper among lighter (versus heavier)
smokers (b= .10, p b .001 and b= .04, p= .022 for lighter and heavier
smokers respectively; see Fig. 1).
In terms of reasons for quitting related to self-control, covariates
entered at the ﬁrst step accounted for a signiﬁcant amount of variance
(R2 = .02, F(10, 455) = 2.2, p b .05). Please refer to Table 1 for signiﬁ-
cant covariate effects. Anxiety sensitivity was the only signiﬁcant
predictor at step two (b = .07, p = .0001). The interaction term for
smoking amount per day was signiﬁcant (b = − .003, p = .01; see
Table 2). Simple slope analyses revealed that anxiety sensitivity
predicted reasons for quitting for self-control among both light and
heavy smokers. However, in line with the signiﬁcant interactive effect,
the change slope was steeper among lighter (versus heavier) smokers
(b= .10, p b .001 and b= .04, p= .046 for lighter and heavier smokers
respectively; see Fig. 1).
4. Discussion
Although past work has indicated that anxiety sensitivity impacts
numerous, clinically-signiﬁcant aspects of smoking behavior (Leventhal
& Zvolensky, 2015), research had not yet explored how this construct
interplays with differing levels of smoking behavior. To address this
gap, the current study explored whether smoking amount per day
would moderate the effect of anxiety sensitivity in regard to nicotine
dependence, smoking outcome expectancies, and (intrinsic) reasons
for quitting among smokerswith lower (versus higher) smoking amount
per day.
Table 2
Main and interactive effects.
Parameter Estimate Standard error t-Value p-Value
Nicotine dependence
Step 1. (R2 = .04, p b .01)
Gendera − .03 .22 −1.17 NS
Negative affectb .02 .02 1.07 NS
AUDITc − .06 .02 −3.08 b .01
Medical problemsd − .19 .17 −1.13 NS
Axis-I disordere .65 .24 2.74 b .01
Substance usef − .30 .37 − .81 NS
Step 2. (R2 = .36, p b 001)
CPDa 0.14 .01 14.73 b .001
ASb 0.03 .01 3.23 b .01
Step 3. (R2 = .37, p b .001)
AS × CPDc − .001 .001 −2.15 b .05
SCQ—neg. consequencesi
Step 1. (R2 = .07, p b .001)
Gendera .39 .12 3.25 b .01
Negative affectb .03 .01 3.58 b .001
AUDITc .01 .01 1.19 NS
Medical problemsd .05 .09 .51 NS
Axis-I disordere − .11 .13 − .81 NS
Substance usef − .41 .21 −1.99 b .05
Step 2. (R2 = .08, p b .001)
ASa .01 .01 1.46 NS
CPDc .01 .01 1.62 NS
Step 3. (R2 = .09, p b .001)
AS × CPDc − .001 .00 −2.5 b .05
SCQ—neg. reinforcementi
Step 1. (R2 = .18, p b .001)
Gendera .48 .16 3.04 b .01
Negative affectb .08 .01 6.8 b .001
AUDITc .02 .01 1.85 NS
Medical problemsd − .32 .12 −2.61 b .01
Axis-I disordere .21 .17 1.19 NS
Substance usef − .25 .27 − .92 NS
Step 2. (R2 = .19, p b .001)
ASa .01 .01 1.75 NS
CPDb .01 .01 0.97 NS
Step 3. (R2 = .19, p b .001)
AS × CPDc − .00007 .00 −1.31 NS
SCQ—appetite controli
Step 1. (R2 = .07, p b .001)
Gendera 1.15 .22 5.25 b .001
Negative affectb .02 .02 1.25 NS
AUDITc .00 .02 .23 NS
Medical problemsd − .04 .17 − .23 NS
Axis-I disordere .19 .24 .79 NS
Substance usef .15 .38 .39 NS
Step 2. (R2 = .08, p b .001)
ASa .02 .01 1.65 NS
CPDb .02 .01 1.49 NS
Step 3. (R2 = .10, p b .001)
AS × CPDc − .002 .00 −2.76 b .01
RFQ—health concernsj
Step 1. (R2 = .06, p b .001)
Gendera 1.08 .36 3.01 b .01
Negative affectb .05 .03 .15 NS
AUDITc .00 .03 .15 NS
Medical problemsd .92 .28 3.25 b .01
Axis-I disordere .24 .40 .60 NS
Substance usef − .99 .62 −1.59 NS
Step 2. (R2 = .11, p b .001)
ASa .08 .02 4.17 b .001
CPDb .04 .02 2.18 b .05
Step 3. (R2 = .12, p b .001)
AS × CPDc − .003 .001 −2.53 b .05
RFQ-Self-Control
Step 1. (R2 = .03, p b .05)
Gendera .59 .38 1.54 NS
Negative affectb − .00 .03 − .03 NS
AUDITc .01 .03 .34 NS
Medical problemsd .59 .30 1.92 =.06
Table 2 (continued)
Parameter Estimate Standard error t-Value p-Value
RFQ-Self-Control
Step 1. (R2 = .03, p b .05)
Axis-I disordere .85 .42 2.01 b .05
Substance usef .01 .66 .01 NS
Step 2. (R2 = .06, p b .001)
ASa .07 .02 3.84 b .001
CPDb .02 .02 1.09 NS
Step 3. (R2 = .07, p b .001)
AS × CPDc − .003 .00 −2.58 =.01
Note: aGender = % listed are females (coded 0 = male; 1 = female). bNA = Positive
and Negative Affect Scale—Negative Affect subscale. cAUDIT = Alcohol Use Disorders
Identiﬁcation Test—total score. dMedical problems = tobacco-related medical illnesses
per the Medical Screening Questionnaire. eAxis I Disorder = Current Axis I disorder per
the Structured Clinical Interview—Non-Patient Version for DSM-IV. eSubstance use =
current non-alcohol substance abuse/dependence diagnosis per the Structured Clinical
Interview—Non-Patient Version for DSM-IV. fCPD = number of cigarettes per day during
past week per the Smoking History Questionnaire. gAS = Anxiety Sensitivity Index-
III—total score. hFTND = Fagerstrom Test for Nicotine Dependence. iSCQ negative
consequences, iSCQ appetite control, iSCQ negative reinforcement = the subscales of
Smoking Consequences Questionnaire. jRFQ health concerns and jRFQ self-control = the
subscales of Reasons for Smoking Scale.
30 C.P. Brandt et al. / Addictive Behaviors Reports 1 (2015) 26–33Results were generally consistent with prediction. Namely, lower
(versus higher) smoking amount per day moderated the relation
between anxiety sensitivity and nicotine dependence, expectancies for
negative consequences and appetite control as well as intrinsic reasons
for quitting. In contrast to expectation, however, no moderating effect
emerged for negative reinforcement/negative affect reduction. The
lack of signiﬁcant interaction for negative reinforcement expectancies
may indicate that smoking amount per day is equally important across
smokers with higher and lower anxiety sensitivity (i.e., the inﬂuence
of the negative reinforcement mechanism may be stronger than that
of smoking amount per day and anxiety sensitivity). The form of the
signiﬁcant interactions indicated across dependent variables lower
levels of smoking amount per day suppressed the relation between
anxiety sensitivity and smoking related dependent variable, such that
the positive relation of anxiety sensitivity to smoking dependence and
cognitive–affective aspects of smoking is weaker in heavier smokers
and more robust in lighter smokers. Thus, although heavier versus
lighter smokers are generally more at risk for tobacco addiction
(e.g., Hatsukami, Stead, & Gupta, 2008), the present ﬁndings indicate
that such main effects may be qualiﬁed by anxiety sensitivity.
Although not a primary aim of the investigation, anxiety sensitivity
and smoking amount per day showed minimal relation to one another;
only sharing approximately .01% overall variance. Such a ﬁnding is
consistent with previous studies (e.g., Howell, Leyro, Hogan, Buckner,
& Zvolensky, 2010) and suggests that they represent distinct biobehav-
ioral processes inﬂuencing tobacco addiction.
The current study suggests that smoking amount per day may
reduce certain processes that tap nicotine dependence and cognitive–
affective aspects of smoking addiction at lower levels of anxiety
sensitivity. Accordingly, ‘early intervention’ for smoking cessation may
beneﬁt by expanding assessment coverage to include anxiety sensitivity.
Indeed, intervention efforts for smoking may beneﬁt by assessing for,
and intervening with, anxiety sensitivity. For example, there may be
clinical utility to target reductions in anxiety sensitivity to improve
cessation outcomes or decrease the severity of nicotine dependence by
addressing this construct via psychoeducation, cognitive restructuring,
and interoceptive exposure (Feldner, Zvolensky, Babson, Leen-Feldner,
& Schmidt, 2008; Zvolensky, Bogiaizian, Salazar, Farris, & Bakhshaie,
2014; Zvolensky, Lejuez, Kahler, & Brown, 2003b; Zvolensky, Yartz,
Gregor, Gonzalez, & Bernstein, 2008).
There are a number of caveats to the present study. First, given the
cross-sectional nature of these data, it is unknown whether smoking
amount per day moderates the above-mentioned effects of anxiety
sensitivity over time. Based upon the present results, future prospective
Fig. 1. Plotting the interactive effects of smoking amount per day (CPD) and anxiety sensitivity (AS) on nicotine dependence, outcome expectancies, and reasons for quitting.
31C.P. Brandt et al. / Addictive Behaviors Reports 1 (2015) 26–33studies are necessary to determine the directional effects of these
relations. Second, our sample consisted of community-recruited,
treatment-seeking daily cigarette smokers with moderate levels of
nicotine dependence. Future studiesmay beneﬁt by sampling from ligh-
ter and heavier smoking populations to ensure the generalizability of
the results to the general smoking population. It also is noteworthy
that the FTND internal consistency was relatively low, a common issue
with this measure (Etter, Vu Duc, & Perneger, 1999), though Cronbach
alpha values are fairly sensitive to the number of items in each scale
and it is not uncommon to ﬁnd lower Cronbach values with shorter
scales (e.g., scales with b 10 items; DeVellis, 2003). Third, the current
study relied solely on self-report measures to assess the examinedpredictor, moderator, and outcome variables. Future research could
beneﬁt by utilizing multi-method approaches and minimizing the role
of method variance in the observed relations. For example, experimen-
tal provocation procedures such as emotion elicitation via biological
challenge could be useful in examining the present relations in response
to aversive interoceptive states elicited ‘in vivo.’ Finally, the sample was
largely comprised of a relatively homogenous group of treatment-
seeking smokers. To rule out a selection bias and increase the generaliz-
ability of these ﬁndings, it will be important for future studies to recruit
a more ethnically/racially diverse sample of smokers.
Overall, the present study serves as an initial investigation into
the interplay between anxiety sensitivity and smoking amount per
32 C.P. Brandt et al. / Addictive Behaviors Reports 1 (2015) 26–33day and a relatively wide range of smoking processes among adult
treatment-seeking smokers. Speciﬁcally, there was generally consistent
evidence that smoking amount per day suppressed the relation
between anxiety sensitivity and smoking related dependent variable,
such that the positive relation of anxiety sensitivity to smoking
dependence and cognitive–affective aspects of smoking is weaker in
heavier smokers and more robust in lighter smokers. Future work is
needed to explore the extent to which anxiety sensitivity interplays
with smoking amount per day in relation to other smoking processes
(e.g., withdrawal, cessation outcome) to further clarify theoretical
models of emotional vulnerability and smoking, and to inform clinical
assessment and intervention development/reﬁnement.
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